WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE)-- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that a poster with preclinical data on the Company’s ...
HerResolve™ first and only assay validated against ground truth of laparoscopy with confirmed histology. Company to Exhibit at Booth #4 BOSTON, MA, UNITED STATES ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results